RayzeBio, Inc. (RYZB)
NASDAQ: RYZB · IEX Real-Time Price · USD
22.37
-0.23 (-1.02%)
Nov 28, 2023, 4:00 PM EST - Market closed
RayzeBio Market Cap
RayzeBio has a market cap or net worth of $1.34 billion as of November 28, 2023.
Market Cap
1.34B
Enterprise Value
809.62M
1-Year Change
n/a
Ranking
Category
Stock Price
$22.37
Market Cap Chart
Since the IPO on September 15, 2023, RayzeBio's market cap has increased from $1.05B to $1.34B, an increase of 27.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2023 | 1.35B | -1.35% |
| Nov 24, 2023 | 1.37B | -2.09% |
| Nov 22, 2023 | 1.40B | 1.39% |
| Nov 21, 2023 | 1.38B | -0.95% |
| Nov 20, 2023 | 1.40B | 2.55% |
| Nov 17, 2023 | 1.36B | 6.77% |
| Nov 16, 2023 | 1.28B | -1.85% |
| Nov 15, 2023 | 1.30B | -0.45% |
| Nov 14, 2023 | 1.31B | 5.99% |
| Nov 13, 2023 | 1.23B | 9.98% |
| Nov 10, 2023 | 1.12B | 1.25% |
| Nov 9, 2023 | 1.11B | -6.37% |
| Nov 8, 2023 | 1.18B | -5.95% |
| Nov 7, 2023 | 1.26B | 3.70% |
| Nov 6, 2023 | 1.21B | -2.05% |
| Nov 3, 2023 | 1.24B | 8.81% |
| Nov 2, 2023 | 1.14B | 1.98% |
| Nov 1, 2023 | 1.11B | 3.82% |
| Oct 31, 2023 | 1.07B | 3.19% |
| Oct 30, 2023 | 1.04B | 2.06% |
| Oct 27, 2023 | 1.02B | -2.80% |
| Oct 26, 2023 | 1.05B | 1.98% |
| Oct 25, 2023 | 1.03B | 0.49% |
| Oct 24, 2023 | 1.02B | -1.07% |
| Oct 23, 2023 | 1.03B | -6.41% |
View and export this data all the way back to 2023.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 1.42B |
| Recursion Pharmaceuticals | 1.41B |
| Summit Therapeutics | 1.41B |
| Merus | 1.40B |
| Twist Bioscience | 1.38B |
| Taro Pharmaceutical Industries | 1.36B |
| Arvinas | 1.33B |
| Veradigm | 1.32B |